SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-16-008162
Filing Date
2016-03-21
Accepted
2016-03-21 06:29:35
Documents
65
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1658025
2 ex23-1.htm EX-23.1 3819
3 ex31-1.htm EX-31.1 11858
4 ex31-2.htm EX-31.2 11838
5 ex32-1.htm EX-32.1 10449
6 image_001.jpg GRAPHIC 61716
7 image_002.jpg GRAPHIC 175602
8 image_003.jpg GRAPHIC 76872
9 image_004.jpg GRAPHIC 92062
10 image_005.jpg GRAPHIC 83283
  Complete submission text file 0001493152-16-008162.txt   5798570

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE rttr-20151231.xml EX-101.INS 620494
12 XBRL SCHEMA FILE rttr-20151231.xsd EX-101.SCH 58474
13 XBRL CALCULATION FILE rttr-20151231_cal.xml EX-101.CAL 50715
14 XBRL DEFINITION FILE rttr-20151231_def.xml EX-101.DEF 191458
15 XBRL LABEL FILE rttr-20151231_lab.xml EX-101.LAB 418538
16 XBRL PRESENTATION FILE rttr-20151231_pre.xml EX-101.PRE 290607
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37428 | Film No.: 161517509
SIC: 2834 Pharmaceutical Preparations